Cardiopulmonary Outcomes of Extreme Prematurity

Seminars in Perinatology

Volumn 32, Issue 1, 2008, Pages 28-34

  Doyle, Lex W ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

blood pressure; infant; preterm; respiratory function

Indexed keywords

BETAMETHASONE; CORTICOSTEROID;

BLOOD PRESSURE; CARDIOPULMONARY HEMODYNAMICS; DISEASE PREDISPOSITION; FORCED EXPIRATORY VOLUME; GESTATIONAL AGE; HUMAN; INTENSIVE CARE; LUNG DISEASE; LUNG FUNCTION; OUTCOME ASSESSMENT; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY FUNCTION; RESPIRATORY TRACT DISEASE; REVIEW; SMOKING; STEROID THERAPY; UNSPECIFIED SIDE EFFECT;

CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; LUNG DISEASES; RESPIRATORY FUNCTION TESTS; RESPIRATORY PHYSIOLOGY; RESPIRATORY SYSTEM;

EID: 38649112025     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2007.12.005     Document Type: Review

References (63)

1. Doyle L.W., and Victorian Infant Collaborative Study Group. Evaluation of neonatal intensive care for extremely low birth weight infants in Victoria over two decades. I. Effectiveness. Pediatrics 113 (2004) 505-509
2. Doyle L.W., and Victorian Infant Collaborative Study Group. Neonatal intensive care at borderline viability-is it worth it?. Early Hum Dev 80 (2004) 103-113
3. Doyle L.W., Gultom E., Chuang S.L., et al. Changing mortality and causes of death in infants 23-27 weeks' gestational age. J Paediatr Child Health 35 (1999) 255-259
4. Northway Jr. W.H., Rosan R.C., and Porter D.Y. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 276 (1967) 357-368
5. Australian Institute of Health and Welfare. Heart, stroke and vascular diseases: Australian facts 2004 (2004), AIHW, National Heart Foundation of Australia, National Stroke Foundation of Australia, Canberra
6. Doyle L.W., Ford G., and Davis N. Health and hospitalistions after discharge in extremely low birth weight infants. Semin Neonatol 8 (2003) 137-145
7. Ford G.W., Rickards A.L., Kitchen W.H., et al. Handicaps and health problems in 2 year old children of birth weight 500 to 1500 g. Aust Paediatr J 21 (1985) 15-22
8. Bowman E., and Yu V.Y. Continuing morbidity in extremely low birthweight infants. Early Hum Dev 18 (1988) 165-174
9. Kitchen W.H., Ford G.W., Doyle L.W., et al. Health and hospital readmissions of very-low-birth-weight and normal-birth-weight children. Am J Dis Child 144 (1990) 213-218
10. Cunningham C.K., McMillan J.A., and Gross S.J. Rehospitalization for respiratory illness in infants of less than 32 weeks' gestation. Pediatrics 88 (1991) 527-532
11. Markestad T., and Fitzhardinge P.M. Growth and development in children recovering from bronchopulmonary dysplasia. J Pediatr 98 (1981) 597-602
12. Yu V.Y., Orgill A.A., Lim S.B., et al. Bronchopulmonary dysplasia in very low birthweight infants. Aust Paediatr J 19 (1983) 233-236
13. Sauve R.S., and Singhal N. Long-term morbidity of infants with bronchopulmonary dysplasia. Pediatrics 76 (1985) 725-733
14. Furman L., Hack M., Watts C., et al. Twenty-month outcome in ventilator-dependent, very low birth weight infants born during the early years of dexamethasone therapy. J Pediatr 126 (1995) 434-440
15. Gregoire M.C., Lefebvre F., and Glorieux J. Health and developmental outcomes at 18 months in very preterm infants with bronchopulmonary dysplasia. Pediatrics 101 (1998) 856-860
16. Furman L., Baley J., Borawski-Clark E., et al. Hospitalization as a measure of morbidity among very low birth weight infants with chronic lung disease. J Pediatr 128 (1996) 447-452
17. Chye J.K., and Gray P.H. Rehospitalization and growth of infants with bronchopulmonary dysplasia: a matched control study. J Paediatr Child Health 31 (1995) 105-111
18. Chien Y.H., Tsao P.N., Chou H.C., et al. Rehospitalization of extremely-low-birth-weight infants in first 2 years of life. Early Hum Dev 66 (2002) 33-40
19. McCormick M.C., Workman-Daniels K., Brooks-Gunn J., et al. Hospitalization of very low birth weight children at school age. J Pediatr 122 (1993) 360-365
20. Doyle L.W., Cheung M.M., Ford G.W., et al. Birth weight <1501 g and respiratory health at age 14. Arch Dis Child 84 (2001) 40-44
21. O'Callaghan M.J., Burns Y., Gray P., et al. Extremely low birth weight and control infants at 2 years corrected age: a comparison of intellectual abilities, motor performance, growth and health. Early Hum Dev 40 (1995) 115-128
22. Tammela O.K. First-year infections after initial hospitalization in low birth weight infants with and without bronchopulmonary dysplasia. Scand J Infect Dis 24 (1992) 515-524
23. Korhonen P., Koivisto A.M., Ikonen S., et al. Very low birthweight, bronchopulmonary dysplasia and health in early childhood. Acta Paediatr 88 (1999) 1385-1391
24. Siltanen M., Savilahti E., Pohjavuori M., et al. Respiratory symptoms and lung function in relation to atopy in children born preterm. Pediatr Pulmonol 37 (2004) 43-49
25. Halvorsen T., Skadberg B.T., Eide G.E., et al. Pulmonary outcome in adolescents of extreme preterm birth: a regional cohort study. Acta Paediatr 93 (2004) 1294-1300
26. Vrijlandt E.J., Gerritsen J., Boezen H.M., et al. Gender differences in respiratory symptoms in 19-year-old adults born preterm. Respir Res 6 (2005) 117
27. Steffensen F.H., Sorensen H.T., Gillman M.W., et al. Low birth weight and preterm delivery as risk factors for asthma and atopic dermatitis in young adult males. Epidemiology 11 (2000) 185-188
28. Ng D.K., Lau W.Y., and Lee S.L. Pulmonary sequelae in long-term survivors of bronchopulmonary dysplasia. Pediatr Int 42 (2000) 603-607
29. Northway Jr. W.H., Moss R.B., Carlisle K.B., et al. Late pulmonary sequelae of bronchopulmonary dysplasia. N Engl J Med 323 (1990) 1793-1799
30. Doyle L.W., Faber B., Callanan C., et al. Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence. Pediatrics 118 (2006) 108-113
31. Vrijlandt E.J., Gerritsen J., Boezen H.M., et al. Lung function and exercise capacity in young adults born prematurely. Am J Respir Crit Care Med 173 (2006) 890-896
32. Anand D., Stevenson C.J., West C.R., et al. Lung function and respiratory health in adolescents of very low birth weight. Arch Dis Child 88 (2003) 135-138
33. Gappa M., Berner M.M., Hohenschild S., et al. Pulmonary function at school-age in surfactant-treated preterm infants. Pediatr Pulmonol 27 (1999) 191-198
34. Pelkonen A.S., Hakulinen A.L., Turpeinen M., et al. Effect of neonatal surfactant therapy on lung function at school age in children born very preterm. Pediatr Pulmonol 25 (1998) 182-190
35. Jobe A.H., and Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163 (2001) 1723-1729
36. Doyle L.W., and Victorian Infant Collaborative Study Group. Respiratory function at age 8-9 Years in extremely low birthweight/very preterm children born in Victoria in 1991-92. Pediatr Pulmonol 41 (2006) 570-576
37. Doyle L.W., Olinsky A., Faber B., et al. Adverse effects of smoking on respiratory function in young adults born weighing less than 1000 grams. Pediatrics 112 (2003) 565-569
38. Higgins M.W., Enright P.L., Kronmal R.A., et al. Smoking and lung function in elderly men and women. The Cardiovascular Health Study. J Am Med Assoc 269 (1993) 2741-2748
39. Dockery D.W., Speizer F.E., Ferris B.G.J., et al. Cumulative and reversible effects of lifetime smoking on simple tests of lung function in adults. Am Rev Respir Dis 137 (1988) 286-292
40. Pharoah P.O., Stevenson C.J., and West C.R. Association of blood pressure in adolescence with birthweight. Arch Dis Child 79 (1998) F114-F118
41. Doyle L.W., Faber B., Callanan C., et al. Blood pressure in late adolescence and very low birth weight. Pediatrics 111 (2003) 252-257
42. Hack M., Schluchter M., Cartar L., et al. Blood pressure among very low birth weight (<1.5 kg) young adults. Pediatr Res 58 (2005) 677-684
43. Cook N.R., Cohen J., Hebert P.R., et al. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med 155 (1995) 701-709
44. Celermajer D.S., Sorensen K.E., Gooch V.M., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340 (1992) 1111-1115
45. Blacher J., Guerin A.P., Pannier B., et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99 (1999) 2434-2439
46. Neunteufl T., Heher S., Katzenschlager R., et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol 86 (2000) 207-210
47. Oren H. Gestational age and birth weight in relation to aortic stiffness in healthy young adults: two separate mechanisms?. Am J Hypertens 16 (2003) 76-79
48. Bonamy A.K., Bendito A., Martin H., et al. Preterm birth contributes to increased vascular resistance and higher blood pressure in adolescent girls. Pediatr Res 58 (2005) 845-849
49. te Velde S.J., Ferreira I., Twisk J.W., et al. Birthweight and arterial stiffness and blood pressure in adulthood: results from the Amsterdam Growth and Health Longitudinal Study. Int J Epidemiol 33 (2004) 154-161
50. Roberts D., and Dalziel S.R. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 3 (2006) CD004454
51. Dodic M., May C.N., Wintour E.M., et al. An early prenatal exposure to excess glucocorticoid leads to hypertensive offspring in sheep. Clin Sci (Lond) 94 (1998) 149-155
52. Seckl J.R. Glucocorticoids, feto-placental 11 beta-hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease. Steroids 62 (1997) 89-94
53. Dalziel S.R., Liang A., Parag V., et al. Blood pressure at 6 years of age after prenatal exposure to betamethasone: follow-up results of a randomized, controlled trial. Pediatrics 114 (2004) e373-e377
54. Dalziel S.R., Walker N.K., Parag V., et al. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet 365 (2005) 1856-1862
55. Halliday H.L., Ehrenkranz R.A., and Doyle L.W. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review). The Cochrane Library (2004), John Wiley and Sons, Chichester Issue 1
56. Halliday H.L., Ehrenkranz R.A., and Doyle L.W. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review). The Cochrane Library (2004), John Wiley and Sons, Chichester Issue 1
57. Halliday H.L., Ehrenkranz R.A., and Doyle L.W. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants (Cochrane Review). The Cochrane Library (2004), John Wiley and Sons, Chichester Issue 1
58. Doyle L.W., Halliday H.L., Ehrenkranz R.A., et al. Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk for chronic lung disease. Pediatrics 115 (2005) 655-661
59. Nixon P.A., Washburn L.K., Schechter M.S., et al. Follow-up study of a randomized controlled trial of postnatal dexamethasone therapy in very low birth weight infants: effects on pulmonary outcomes at age 8 to 11 years. J Pediatr 150 (2007) 345-350
60. Gross S.J., Anbar R.D., and Mettelman B.B. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease. Pediatrics 115 (2005) 681-687
61. Yeh T.F., Lin Y.J., Lin H.C., et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 350 (2004) 1304-1313
62. Jones R.A. Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study. II. Respiratory status, growth, and blood pressure. Pediatrics 116 (2005) 379-384
63. Washburn L.K., Nixon P.A., and O'Shea T.M. Follow-up of a randomized, placebo-controlled trial of postnatal dexamethasone: blood pressure and anthropometric measurements at school age. Pediatrics 118 (2006) 1592-1599